Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase

Abstract

Scatter factor (SF) [aka. hepatocyte growth factor (HGF)] (designated HGF/SF) is a multifunctional cytokine that stimulates tumor cell invasion and angiogenesis. We recently reported that HGF/SF protects epithelial and carcinoma cells against cytotoxicity from DNA-damaging agents and that HGF/SF-mediated cytoprotection was associated with up-regulation of the anti-apoptotic protein Bcl-XL in cells exposed to adriamycin. We now report that in addition to blocking apoptosis, HGF/SF markedly enhances the repair of DNA strand breaks caused by adriamycin or gamma radiation. Constitutive expression of Bcl-XL in MDA-MB-453 breast cancer cells not only simulated the HGF/SF-mediated chemoradioresistance, but also enhanced the repair of DNA strand breaks. The ability of HGF/SF to induce both chemoresistance and DNA repair was inhibited by wortmannin, suggesting that these activities of HGF/SF are due, in part, to a phosphatidylinositol-3′-kinase (PI3K) dependent signaling pathway. Consistent with this finding, HGF/SF induced the phosphorylation of c-Akt (protein kinase-B), a PI3K substrate implicated in apoptosis inhibition; and an expression vector encoding a dominant negative kinase inactive Akt partially but significantly inhibited HGF/SF-mediated cell protection and DNA repair. These findings suggest that HGF/SF activates a cell survival and DNA repair pathway that involves signaling through PI3K and c-Akt and stabilization of the expression of Bcl-XL; and they implicate Bcl-XL in the DNA repair process.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Alley MC, Scudieco DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR . 1988 Cancer Res 48: 589–601

  • Amicone L, Spagnoli FM, Spath G, Giordano S, Tommasini C, Bernardini S, De Luca V, Della Roca C, Weiss MC, Comoglio PM and Tripodi M . 1997 EMBO J 16: 495–503

  • Bardelli A, Longatti P, Albero D, Goruppi S, Schneider C, Ponzetto C and Comoglio PM . 1996 EMBO J 15: 6205–6212

  • Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W . 1996 Nature 382: 638–642

  • Bertrand R and Pommier Y . 1995 Cell Growth and Apoptosis, Studzinski GP, ed. University Press Oxford pp 97–117

  • Boise LH, Gonzalez-Garcia M, Postima CE, Ding L, Lindstem T, Turka LA, Mao X, Nunez G and Thompson CB . 1993 Cell 74: 597–608

  • Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF and Aaronson SA . 1991 Science 251: 802–804

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME . 1999 Cell 90: 857–868

  • Chao DT and Korsmeyer SJ . 1998 Annu Rev Immunol 16: 395–419

  • Chen L, Liu TH and Walworth NC . 1999 Genes Dev 13: 675–685

  • Cong LN, Chen H, Zhou L, McGibbon MA, Taylor SC and Quon MJ . 1997 Mol Endocrinol 11: 1881–1890

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . 1997 Cell 91: 231–241

  • Depraetere V and Goldstein P . 1997 Semin Oncol 9: 93–107

  • Fan S, Wang J-A, Yuan R-Q, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID and Rosen EM . 1998a Oncogene 17: 131–141

  • Fan S, Wang J-A, Yuan R-Q, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID and Rosen EM . 1998b Oncogene 16: 3069–3082

  • Friedlander RM, Gagliardini V, Rotello RJ and Yuan J . 1996 J Exp Med 184: 717–724

  • Frisch SM and Francis H . 1994 J Cell Biol 124: 619–626

  • Gowen LC, Avrutskaya AV, Latour AM, Koller BH and Leadon SA . 1998 Science 281: 1009–1012

  • Grant DS, Kleinman HK, Goldberg ID, Bhargava M, Nickoloff BJ, Polverini P and Rosen EM . 1993 Proc Natl Acad Sci USA 90: 1937–1941

  • Hermann M, Lorenz HM, Voll R, Grunke M, Woith W and Kalden JR . 1994 Nucl Acids Res 22: 5506–5507

  • Husain A, He G, Venkatraman ES and Spriggs DR . 1998 Cancer Res 58: 1120–1130

  • Jin L, Fuchs A, Schnitt SS, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID and Rosen EM . 1997 Cancer 79: 749–760

  • Kang SS, Kwon T, Kwon DY and Do SI . 1999 J Biol Chem 274: 13085–13090

  • Kennedy SG, Kandel ES, Cross TK and Hay N . 1999 Mol Cell Biol 19: 5800–5810

  • Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN and Hay N . 1997 Genes Dev 11: 701–713

  • Kolik G, Klippel A and Weber JJ . 1997 Mol Cell Biol 17: 1595–1606

  • Muchmore Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SC and Fesik SW . 1996 Nature 382: 335–341

  • Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z and Rotter V . 1999 FEBS Lett 450: 197–204

  • Packham G, Porter CW and Cleveland JL . 1996 Oncogene 13: 461–469

  • Pap M and Cooper GM . 1998 J Biol Chem 273: 19929–19932

  • Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P and Baserga R . 1995 Cancer Res 55: 2463–2469

  • Rodriguez C, Lacasse and Hoang T . 1996 J Cell Physiol 166: 387–396

  • Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S and Vande Woude GF . 1992 Mol Cell Biol 12: 5152–5158

  • Saelman EU, Keely PJ and Santara SA . 1995 J Cell Sci 108: 3531–3540

  • Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME . 1998 Eur J Biochem 254: 439–459

  • Shao N, Chai YL, Shyam E, Reddy P and Rao VM . 1996 Oncogene 13: 1–7

  • Singleton JR, Dixit VM and Feldman EL . 1996 J Biol Chem 271: 31791–31794

  • Smith GC, di Fagagna F, Lakin ND and Jackson SP . 1999 Mol Cell Biol 19: 6076–6084

  • Stoker M, Gherardi E, Perryman M and Gray J . 1987 Nature 327: 238–242

  • Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC . 1995 Nat Genet 10: 188–195

  • Waterman MJ, Stavridi ES, Waterman JL and Halazonetis TD . 1998 Nat Genet 19: 175–178

  • Weidner KM, Di Cesare S, Sachs M, Brinkman V, Behrens J and Birchmeier W . 1996 Nature 384: 173–176

  • Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S . 1994 Cancer Res 54: 1630–1633

  • Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ . 1995 Cell 80: 285–291

  • Yao Y, Jin L, Fuchs A, Joseph A, Hastings H, Goldberg ID and Rosen EM . 1996 Am J Pathol 149: 1707–1717

  • Zha J, Harada H, Osipov K, Jockel J, Waksman G and Korsemeyer SJ . 1997 J Biol Chem 272: 24101–24104

  • Zha J, Harada H, Yang E, Jockel J and Korsemeyer SJ . 1996 Cell 87: 619–628

Download references

Acknowledgements

Sources of Support: Supported, in part, by research grants from the USPHS [R01-ES09169 (EM Rosen) and RO1-NS/CA32148 (JJ Laterra)], the Elsa U. Pardee Cancer Foundation of Michigan (EM Rosen), and the New York State Department of Health (EM Rosen).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, S., Ma, Y., Wang, JA. et al. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 19, 2212–2223 (2000). https://doi.org/10.1038/sj.onc.1203566

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203566

Keywords

Search

Quick links